Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1953 1
1993 1
1994 1
1995 5
1996 6
1997 2
1998 3
1999 8
2000 6
2001 9
2002 4
2003 6
2004 9
2005 7
2006 6
2007 8
2008 9
2009 10
2010 11
2011 8
2012 9
2013 5
2014 15
2015 10
2016 13
2017 9
2018 9
2019 8
2020 9
2021 9
2022 4
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Results by year

Filters applied: . Clear all
Page 1
VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects.
Bazan-Peregrino M, Garcia-Carbonero R, Laquente B, Álvarez R, Mato-Berciano A, Gimenez-Alejandre M, Morgado S, Rodríguez-García A, Maliandi MV, Riesco MC, Moreno R, Ginestà MM, Perez-Carreras M, Gornals JB, Prados S, Perea S, Capella G, Alemany R, Salazar R, Blasi E, Blasco C, Cascallo M, Hidalgo M. Bazan-Peregrino M, et al. Among authors: alemany r. J Immunother Cancer. 2021 Nov;9(11):e003254. doi: 10.1136/jitc-2021-003254. J Immunother Cancer. 2021. PMID: 35149591 Free PMC article. Clinical Trial.
Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors.
Garcia-Carbonero R, Bazan-Peregrino M, Gil-Martín M, Álvarez R, Macarulla T, Riesco-Martinez MC, Verdaguer H, Guillén-Ponce C, Farrera-Sal M, Moreno R, Mato-Berciano A, Maliandi MV, Torres-Manjon S, Costa M, Del Pozo N, Martínez de Villarreal J, Real FX, Vidal N, Capella G, Alemany R, Blasi E, Blasco C, Cascalló M, Salazar R. Garcia-Carbonero R, et al. Among authors: alemany r. J Immunother Cancer. 2022 Mar;10(3):e003255. doi: 10.1136/jitc-2021-003255. J Immunother Cancer. 2022. PMID: 35338084 Free PMC article.
Cancer selective adenoviruses.
Alemany R. Alemany R. Mol Aspects Med. 2007 Feb;28(1):42-58. doi: 10.1016/j.mam.2006.12.002. Epub 2007 Jan 10. Mol Aspects Med. 2007. PMID: 17300834 Review.
Viruses in cancer treatment.
Alemany R. Alemany R. Clin Transl Oncol. 2013 Mar;15(3):182-8. doi: 10.1007/s12094-012-0951-7. Epub 2012 Nov 10. Clin Transl Oncol. 2013. PMID: 23143950 Review.
Evolving Status of Clinical Immunotherapy with Oncolytic Adenovirus.
Farrera-Sal M, Moya-Borrego L, Bazan-Peregrino M, Alemany R. Farrera-Sal M, et al. Among authors: alemany r. Clin Cancer Res. 2021 Jun 1;27(11):2979-2988. doi: 10.1158/1078-0432.CCR-20-1565. Epub 2021 Feb 1. Clin Cancer Res. 2021. PMID: 33526422 Review.
Oncolytic Adenoviruses in Cancer Treatment.
Alemany R. Alemany R. Biomedicines. 2014 Feb 21;2(1):36-49. doi: 10.3390/biomedicines2010036. Biomedicines. 2014. PMID: 28548059 Free PMC article. Review.
Oncolytic virotherapy for neuroblastoma.
Ramírez M, García-Castro J, Alemany R. Ramírez M, et al. Among authors: alemany r. Discov Med. 2010 Nov;10(54):387-93. Discov Med. 2010. PMID: 21122470 Free article. Review.
199 results